ADVFN - Advanced Financial Network.
HOME» NYSE » V » VRX Stock Price » VRX Stock News

Valeant Pharma Share News

 Valeant Pharmaceuticals International Stock Price
VRX Stock Price
 Valeant Pharmaceuticals International Stock Chart
VRX Stock Chart
 Valeant Pharmaceuticals International Stock News
VRX Stock News
 Valeant Pharmaceuticals International Company Information
VRX Company Information
 Valeant Pharmaceuticals International Stock Trades
VRX Stock Trades

FTC Seeks Additional Info From Teva, Cephalon Regarding Merger

DOW JONES NEWSWIRES Teva Pharmaceutical Industries Ltd. (TEVA, TEVA.TV) and acquisition target Cephalon Inc. (CEPH) each received a request to provide additional information to the U.S. Federal Trade Commission related to a pending $6.8 billion deal between the firms. Israel-based Teva, which trumped a hostile offer from Valeant Pharmaceuticals International Inc. (VRX) in agreeing to buy Cephalon last month, said it had expected the request. The parties have been cooperating with the FTC staff since shortly after the bid was announced, according to Teva, which said it intends to win clearance "as promptly as possible." Teva on Monday said it continues to expect the deal to be completed in the third quarter, following clearance from U.S. and European regulators, as well as winning approval of Cephalon shareholders. Teva's American depositary shares were recently up 0.4% to $49.35 in after-hours trading. -By John Kell, Dow Jones Newswires; 212-416-2480; john.kell@dowjones.com

Stock News for Valeant Pharma (VRX)
DateTimeHeadline
03/02/201517:30:14Salix Posts Loss Amid Push to Clear Inventory
02/23/201517:04:20U.S. Stocks Decline, Mirroring Oil's Resumed Drop
02/23/201517:00:34MARKET SNAPSHOT: Dow, S&P Slump; Nasdaq Marks 9-session Win Streak
02/23/201515:52:37MARKET SNAPSHOT: Stocks Retreat From Records As Oil Drop Hits...
02/23/201513:39:04MARKET SNAPSHOT: U.S. Stocks Give Up Records As Oil Drop Hits...
02/23/201513:33:18MARKET SNAPSHOT: U.S. Stocks Slide As Oil Drop Hits Energy Companies
02/23/201513:29:14MARKET SNAPSHOT: U.S. Stocks: Futures Dip As Oil Slide Hits Energy...
02/23/201513:17:27MARKET SNAPSHOT: U.S. Stocks: Futures Dip Ahead Of Home Sales...
02/23/201511:03:56MARKET SNAPSHOT: U.S. Stocks: Futures Dip Ahead Of Home Sales...
02/22/201517:20:08Valeant Pharmaceuticals to Buy Salix for About $10 Billion...
02/22/201517:05:14Valeant Pharmaceuticals to Buy Salix for About $10 Billion...
02/22/201516:52:15Valeant Pharmaceuticals to Buy Salix for About $10 Billion
02/21/201517:02:14Valeant Nears Deal to Buy Salix
02/20/201514:57:21Valeant Approved to Buy Dendreon Assets for $495 Million

Valeant Pharma and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad